By Stephen Nakrosis
EXoZymes and MDB Capital Holdings said Mo Hayat has transitioned out of his roles as chairman and president. Christopher Marlett, MDB's chief executive, will become chairman.
Marlett will ensure MDB will continue to provide help and support for eXoZymes, the company said Friday. Hayat will focus on new MDB Capital ventures.
Edgardo Rayo will also join the board on behalf of MDB Capital, according to eXoZymes.
The transition follows eXoZymes' corporate rebranding from Invizyne Technologies, which took place earlier this month. Shares trade on the Nasdaq under the symbol EXOZ.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
February 21, 2025 16:47 ET (21:47 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。